Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins - PubMed (original) (raw)

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

A M Schmidt et al. Proc Natl Acad Sci U S A. 1994.

Abstract

The extended interaction of aldoses with proteins or lipids results in nonenzymatic glycation and oxidation, ultimately forming AGEs, the presence of which in the plasma and vessel wall is associated with diabetic vascular complications. We show here that AGE albumin in the intravascular space interacts with the vessel wall via binding to an integral membrane protein, receptor for AGE (RAGE), a member of the immunoglobulin superfamily, resulting in clearance from the plasma and induction of interleukin 6 mRNA. Intravenously infused 125I-AGE albumin showed a rapid phase of plasma clearance with deposition in several organs. Rapid removal of 125I-AGE albumin from the plasma was prevented by administration of a soluble, truncated form of RAGE, which blocked binding of 125I-labeled AGE albumin to cultured endothelial cells and mononuclear phagocytes, as well as by pretreatment with anti-RAGE IgG. Ultrastructural studies with AGE albumin-colloidal gold conjugates perfused in situ showed that in murine coronary vasculature this probe was taken up by endothelial plasmalemmal vesicles followed by transport either to the abluminal surface or by accumulation in intracellular vesicular structures reminiscent of endosomes and lysosomes. Consequences of AGE-RAGE interaction included induction of interleukin 6 mRNA expression in mice. These data indicate that RAGE mediates the interaction of AGEs with the vessel wall, both for removal of these glycated proteins from the plasma and for changes in gene expression.

PubMed Disclaimer

Cited by

The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.
Ge Y, Huang M, Yao YM. Ge Y, et al. Cells. 2021 Apr 28;10(5):1044. doi: 10.3390/cells10051044. Cells. 2021. PMID: 33925132 Free PMC article. Review.
Ciprofloxacin inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes.
Mori S, Takahashi HK, Liu K, Wake H, Zhang J, Liu R, Yoshino T, Nishibori M. Mori S, et al. Br J Pharmacol. 2010 Sep;161(1):229-40. doi: 10.1111/j.1476-5381.2010.00880.x. Br J Pharmacol. 2010. PMID: 20718752 Free PMC article.
Aging is not a disease: distinguishing age-related macular degeneration from aging.
Ardeljan D, Chan CC. Ardeljan D, et al. Prog Retin Eye Res. 2013 Nov;37:68-89. doi: 10.1016/j.preteyeres.2013.07.003. Epub 2013 Aug 9. Prog Retin Eye Res. 2013. PMID: 23933169 Free PMC article. Review.
Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk.
Chiappalupi S, Salvadori L, Donato R, Riuzzi F, Sorci G. Chiappalupi S, et al. Biomolecules. 2021 Jun 12;11(6):876. doi: 10.3390/biom11060876. Biomolecules. 2021. PMID: 34204735 Free PMC article. Review.
Lipopolysaccharides induce a RAGE-mediated sensitization of sensory neurons and fluid hypersecretion in the upper airways.
Nair M, Jagadeeshan S, Katselis G, Luan X, Momeni Z, Henao-Romero N, Chumala P, Tam JS, Yamamoto Y, Ianowski JP, Campanucci VA. Nair M, et al. Sci Rep. 2021 Apr 16;11(1):8336. doi: 10.1038/s41598-021-86069-6. Sci Rep. 2021. PMID: 33863932 Free PMC article.

References

1. Biochem Biophys Res Commun. 1990 Dec 31;173(3):932-9 - PubMed
1. Proc Natl Acad Sci U S A. 1990 Nov;87(22):9010-4 - PubMed
1. J Biol Chem. 1991 Jun 25;266(18):11654-60 - PubMed
1. J Exp Med. 1991 Sep 1;174(3):515-24 - PubMed
1. J Clin Invest. 1991 Oct;88(4):1173-81 - PubMed

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins - PubMed (original) (raw)